Mezzion Pharma (140410) Financial Statements

Income Statement

YearRevenueOp ProfitNet IncomeSource
2025-16.8 billion KRW-34.9 billion KRW[source]
2024-14.3 billion KRW-19.5 billion KRW[source]
2023-14.5 billion KRW-12.7 billion KRW[source]
2022-23.3 billion KRW-36.3 billion KRW[source]
2021-16.8 billion KRW[source]

Balance Sheet

YearTotal AssetsTotal LiabilitiesTotal EquitySource
202581.3 billion KRW65.3 billion KRW16.0 billion KRW[source]
202462.2 billion KRW16.9 billion KRW45.3 billion KRW[source]
202375.1 billion KRW14.0 billion KRW61.1 billion KRW[source]
202251.2 billion KRW21.6 billion KRW29.5 billion KRW[source]
202181.8 billion KRW19.0 billion KRW62.8 billion KRW[source]

This company has no revenue account in the DART financial statements. Industry-specific accounts such as insurance or interest income are not converted to revenue.

Figures for the relevant year were not collected.